“Explore medicine prescribing and administration in the palliative patient”
AATD is a rare genetic condition estimated to affect approximately 1 in 300 people in Australia. Early symptoms are often misdiagnosed as asthma, with an accurate diagnosis often taking several years.
Alpha-1 Antitrypsin deficiency (AATD) is a genetic condition that may result in lung and/or liver disease. Alpha-1 Antitrypsin is a protein whose primary function is to protect the lungs from neutrophil disease.
In this session, you will:
- Review the recommended Clinical Practice Guidelines for Alpha-1
- Define Alpha-1 Antitrypsin Deficiency
- Understand the challenges of diagnosis & treatment for Alpha-1 patients
- Acquire knowledge about the recommended treatment pathways for Alpha-1 patients
Nurses are the backbone of health care – the knowledge base of each individual Nurse has a direct impact on the happiness and experience of the recipients of health care services. We are dedicated to providing you with a comprehensive, continually updated CPD library at an affordable price – saving you time and money.